SPY323.01-0.49 -0.15%
DIA267.52-0.58 -0.22%
IXIC10,668.80-3.47 -0.03%

Morgan Stanley Maintains Overweight on Sage Therapeutics, Raises Price Target to $87

Morgan Stanley maintains Sage Therapeutics (NASDAQ:SAGE) with a Overweight and raises the price target from $85 to $87.

Benzinga · 08/24/2020 12:16
Morgan Stanley maintains Sage Therapeutics (NASDAQ: SAGE) with a Overweight and raises the price target from $85 to $87.